CN110438092B - 病毒运送培养基及其制备方法和应用 - Google Patents
病毒运送培养基及其制备方法和应用 Download PDFInfo
- Publication number
- CN110438092B CN110438092B CN201910753295.2A CN201910753295A CN110438092B CN 110438092 B CN110438092 B CN 110438092B CN 201910753295 A CN201910753295 A CN 201910753295A CN 110438092 B CN110438092 B CN 110438092B
- Authority
- CN
- China
- Prior art keywords
- days
- examples
- stored
- virus
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 107
- 239000001963 growth medium Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 239000000243 solution Substances 0.000 claims abstract description 28
- 239000006163 transport media Substances 0.000 claims abstract description 28
- 108010071390 Serum Albumin Proteins 0.000 claims abstract description 9
- 102000007562 Serum Albumin Human genes 0.000 claims abstract description 9
- 150000001413 amino acids Chemical class 0.000 claims abstract description 8
- 239000006177 biological buffer Substances 0.000 claims abstract description 7
- 150000002016 disaccharides Chemical class 0.000 claims abstract description 7
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 3
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 150000003839 salts Chemical class 0.000 claims abstract description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 16
- 239000012981 Hank's balanced salt solution Substances 0.000 claims description 12
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 12
- 238000004321 preservation Methods 0.000 claims description 11
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical group OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 9
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 9
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 9
- 229930182566 Gentamicin Natural products 0.000 claims description 9
- 108010093965 Polymyxin B Proteins 0.000 claims description 9
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 9
- 229960003942 amphotericin b Drugs 0.000 claims description 9
- 229960002518 gentamicin Drugs 0.000 claims description 9
- 229920000024 polymyxin B Polymers 0.000 claims description 9
- 229960005266 polymyxin b Drugs 0.000 claims description 9
- 229960002989 glutamic acid Drugs 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 229940024606 amino acid Drugs 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 239000004201 L-cysteine Substances 0.000 claims description 6
- 235000013878 L-cysteine Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000012984 antibiotic solution Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 125000000185 sucrose group Chemical group 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 230000015556 catabolic process Effects 0.000 abstract description 5
- 238000006731 degradation reaction Methods 0.000 abstract description 5
- 230000003115 biocidal effect Effects 0.000 abstract description 3
- 241001122767 Theaceae Species 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 160
- 238000003860 storage Methods 0.000 description 18
- 230000003385 bacteriostatic effect Effects 0.000 description 15
- 238000003753 real-time PCR Methods 0.000 description 13
- 102000039446 nucleic acids Human genes 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 7
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 241000222122 Candida albicans Species 0.000 description 6
- 239000000022 bacteriostatic agent Substances 0.000 description 6
- 229940095731 candida albicans Drugs 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 241001429382 Coxsackievirus A16 Species 0.000 description 4
- 241001529459 Enterovirus A71 Species 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 241000712431 Influenza A virus Species 0.000 description 3
- 241000725643 Respiratory syncytial virus Species 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 2
- 241000252870 H3N2 subtype Species 0.000 description 2
- 241000726041 Human respirovirus 1 Species 0.000 description 2
- 241000713196 Influenza B virus Species 0.000 description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000712003 Human respirovirus 3 Species 0.000 description 1
- 241000430519 Human rhinovirus sp. Species 0.000 description 1
- 241000134304 Influenza A virus H3N2 Species 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 210000004777 protein coat Anatomy 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229930185603 trichostatin Natural products 0.000 description 1
- RTKIYFITIVXBLE-QEQCGCAPSA-N trichostatin A Chemical compound ONC(=O)/C=C/C(/C)=C/[C@@H](C)C(=O)C1=CC=C(N(C)C)C=C1 RTKIYFITIVXBLE-QEQCGCAPSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Abstract
Description
组分名称 | 贮存液浓度 | 用量 | 终浓度 |
Hank’s平衡盐溶液 | 4× | 125mL | 0.5× |
明胶 | 5% | 20mL | 1g/L |
BSA | 10% | 25mL | 2.5g/L |
蔗糖 | 5% | 20mL | 1g/L |
L-半胱氨酸 | 0.015mmol/mL | 6.6mL | 0.1mM/L |
L-谷氨酸 | 0.015mmol/mL | 6.6mL | 0.1mM/L |
Hepes | 1M/L | 5mL | 5mM/L |
两性霉素B | 2.5mg/mL | 4mL | 10mg/L |
多粘菌素B | 2mg/mL | 5mL | 10mg/L |
庆大霉素 | 10mg/mL | 1mL | 10mg/L |
水 | / | 定容至1L | / |
组分名称 | 贮存液浓度 | 用量(配制1L) | 终浓度 |
Hank’s平衡盐溶液 | 4× | 250mL | 1× |
明胶 | 5% | 50mL | 2.5g/L |
BSA | 10% | 50mL | 5g/L |
蔗糖 | 5% | 50mL | 2.5g/L |
L-半胱氨酸 | 0.015mmol/mL | 10mL | 0.150mM/L |
L-谷氨酸 | 0.015mmol/mL | 10mL | 0.150mM/L |
Hepes | 1M | 10mL | 10mM/L |
两性霉素B | 2.5mg/mL | 8mL | 20mg/L |
多粘菌素B | 2mg/mL | 10mL | 20mg/L |
庆大霉素 | 10mg/mL | 2mL | 20mg/L |
水 | / | 定容至1L | / |
组分名称 | 贮存液浓度 | 用量(配制1L) | 终浓度 |
Hank’s平衡盐溶液 | 4× | 500mL | 2× |
明胶 | 5% | 100mL | 5g/L |
BSA | 10% | 100mL | 10g/L |
蔗糖 | 5% | 100mL | 5g/L |
L-半胱氨酸 | 0.015mmol/mL | 20mL | 0.3mM/L |
L-谷氨酸 | 0.015mmol/mL | 20mL | 0.3mM/L |
Hepes | 1M | 20mL | 20mM/L |
两性霉素B | 2.5mg/mL | 16mL | 40mg/L |
多粘菌素B | 2mg/mL | 20mL | 40mg/L |
庆大霉素 | 10mg/mL | 4mL | 40mg/L |
水 | / | 定容至1L | / |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910753295.2A CN110438092B (zh) | 2019-08-15 | 2019-08-15 | 病毒运送培养基及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910753295.2A CN110438092B (zh) | 2019-08-15 | 2019-08-15 | 病毒运送培养基及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110438092A CN110438092A (zh) | 2019-11-12 |
CN110438092B true CN110438092B (zh) | 2021-07-06 |
Family
ID=68435740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910753295.2A Active CN110438092B (zh) | 2019-08-15 | 2019-08-15 | 病毒运送培养基及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110438092B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110982876B (zh) * | 2020-03-04 | 2020-05-26 | 圣湘生物科技股份有限公司 | 病毒核酸检测的预处理方法、预处理液、试剂盒及其用途 |
CN111876330B (zh) * | 2020-07-07 | 2022-08-30 | 广州金域医学检验中心有限公司 | 一种适用于核酸检测的病毒运送培养基及其制备方法 |
CN112314593A (zh) * | 2020-11-03 | 2021-02-05 | 武汉尚飞生物科技有限公司 | 一种适用于病毒样本常温保存的保存液及其制备方法 |
WO2022101877A1 (pt) * | 2020-11-13 | 2022-05-19 | Targetalent, Lda | Composição de criopreservação de amostras biológicas para pcr |
CN112779164A (zh) * | 2021-01-28 | 2021-05-11 | 苏州赛普生物科技有限公司 | 一种病毒运送培养基 |
CN113462815B (zh) * | 2021-06-17 | 2023-11-24 | 深圳逗点生物技术有限公司 | 病毒培养基及其制备方法、病毒转运培养瓶和病毒采样管 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420185A (zh) * | 2015-12-11 | 2016-03-23 | 郭镭 | 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法 |
CN109652362A (zh) * | 2017-10-12 | 2019-04-19 | 北京弘润天源基因生物技术有限公司 | 一种脐带膜保存和制备干细胞的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250410A (en) * | 1987-01-27 | 1993-10-05 | Allegheny-Singer Research Institute | Rapid detection of herpes virus with lectin |
CN102337249A (zh) * | 2010-07-23 | 2012-02-01 | 复旦大学 | 一种mhv混合细胞培养多种病毒的培养方法 |
CN101979516B (zh) * | 2010-10-19 | 2013-07-03 | 李海波 | 一种病毒采样液组合物 |
CN107384871A (zh) * | 2017-07-24 | 2017-11-24 | 青岛金典生化器材有限公司 | 一种用于培养病毒的培养基及其制备方法 |
CN110066887A (zh) * | 2018-01-23 | 2019-07-30 | 上海钰森生物技术有限公司 | 一种病毒运送培养基及其配制方法 |
-
2019
- 2019-08-15 CN CN201910753295.2A patent/CN110438092B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420185A (zh) * | 2015-12-11 | 2016-03-23 | 郭镭 | 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法 |
CN109652362A (zh) * | 2017-10-12 | 2019-04-19 | 北京弘润天源基因生物技术有限公司 | 一种脐带膜保存和制备干细胞的方法 |
Non-Patent Citations (2)
Title |
---|
Screening Helicobacter pylori genes induced during infection of mouse stomachs;Aparna Singh等;《World Journal of Gastroenterology》;20120828;第18卷(第32期);第4323-4334页 * |
贮存病毒的新方法;育巍;《国外医学情报》;19980315(第3期);第44页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110438092A (zh) | 2019-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110438092B (zh) | 病毒运送培养基及其制备方法和应用 | |
Turgeon et al. | Comparison of five bacteriophages as models for viral aerosol studies | |
Zuo et al. | Survival of airborne MS2 bacteriophage generated from human saliva, artificial saliva, and cell culture medium | |
EP2882842B1 (en) | Method of making agglomerated microbiological media and compositions thereof | |
CN105498558A (zh) | 负载银纳米颗粒的杂化膜及其制备方法和用途 | |
EP4038183A1 (en) | Method for purification of bacteriophage particles | |
CN112779316A (zh) | 一种灭活型病毒保存液及其制备方法 | |
Xu et al. | Detection of viral components in exosomes derived from NDV-infected DF-1 cells and their promoting ability in virus replication | |
CN110684741B (zh) | 一种弧菌噬菌体及其应用 | |
CN115612675A (zh) | 一株沙门氏菌噬菌体nct1及其应用 | |
US10196675B2 (en) | Solid medium for the storage of biological material | |
CN104498443B (zh) | 鲍曼不动杆菌噬菌体及其应用 | |
CN117050954B (zh) | 一种宽谱沙门氏菌噬菌体vB-SenS-S1及包含该噬菌体的组合物 | |
CN112779164A (zh) | 一种病毒运送培养基 | |
CN105535981B (zh) | 一种耐热保护剂、禽用耐热保护剂活疫苗及其制备方法 | |
CN109593114B (zh) | 一种黄蛞蝓抗菌肽、提取方法及其应用 | |
Vázquez‐Salgado et al. | Nervous necrosis virus viability modulation by water salinity and temperature | |
Ahiwale et al. | Liquid based formulations of bacteriophages for the management of waterborne bacterial pathogens in water microcosms | |
CN117025553B (zh) | 一种在非超低温下保持病毒活力的病毒保存液及其制备方法 | |
Dhakal et al. | Method validation for the recovery of the porcine respiratory and reproductive syndrome virus, a potential SARS-CoV-2 surrogate, from stainless steel | |
Dallal et al. | Isolation of E. Coli bacteriophage from raw sewage and comparing its antibacterial effect with ceftriaxone antibiotic | |
Yang et al. | Study on an air filter material immobilized with bio-antimicrobials | |
CN110583697A (zh) | 去除铜绿假单胞菌生物膜用的高效化学生物制剂及其应用 | |
CN113462815B (zh) | 病毒培养基及其制备方法、病毒转运培养瓶和病毒采样管 | |
CN114836330B (zh) | 一种蜡样芽孢杆菌的抑制物制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20191112 Assignee: Zhengzhou Jinyu Clinical Laboratory Center Co.,Ltd. Assignor: GUANGZHOU KINGMED DIAGNOSTICS GROUP Co.,Ltd. Contract record no.: X2021980010019 Denomination of invention: Virus delivery medium and its preparation method and Application Granted publication date: 20210706 License type: Common License Record date: 20210928 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Zhengzhou Jinyu Clinical Laboratory Center Co.,Ltd. Assignor: GUANGZHOU KINGMED DIAGNOSTICS GROUP Co.,Ltd. Contract record no.: X2021980010019 Date of cancellation: 20220922 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20191112 Assignee: Zhengzhou Jinyu Clinical Laboratory Center Co.,Ltd. Assignor: GUANGZHOU KINGMED DIAGNOSTICS GROUP Co.,Ltd. Contract record no.: X2022980016522 Denomination of invention: Virus delivery medium and its preparation and application Granted publication date: 20210706 License type: Common License Record date: 20220927 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
CP02 | Change in the address of a patent holder |
Address after: 510005 No. 10, helix 3 Road, International Biological Island, Huangpu District, Guangzhou, Guangdong Patentee after: GUANGZHOU KINGMED CENTER FOR CLINICAL LABORATORY Patentee after: GUANGZHOU KINGMED DIAGNOSTICS GROUP Co.,Ltd. Address before: 510335 3rd floor, 2429 Xingang East Road, Haizhu District, Guangzhou City, Guangdong Province Patentee before: GUANGZHOU KINGMED CENTER FOR CLINICAL LABORATORY Patentee before: GUANGZHOU KINGMED DIAGNOSTICS GROUP Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |